Age

20–85

Sex

FEMALE

Healthy volunteers

Not accepted

breast cancer patients aged between 20- and 80-years-old with CIPN
history of receiving chemotherapy including taxane-based neurotoxic agents
with neuropathic pain, score≥3 in a 0-10 VAS pain scale.
with fair cognition and can cooperate to evaluate pain severity.
neither at end-stage cancer nor at the estimated survival time less than 6 months.

brain tumor or history of epilepsy
intracranial metallic devices, artificial cochleae, pacemakers, or any other metal device
recent myocardial ischemia or unstable angina
severe cognitive dysfunction or pregnancy
injuries or fractures in the part of neuropathic pain

Network-Guided Theta Burst Stimulation for Breast Cancer With Chemotherapy-Induced Peripheral Neuropathy: Clinical and fMRI Biomarker Evidence